Hol JA, Lopez-Yurda MI, Van Tinteren H, Van Grotel M1, Godzinski J, Vujanic G, Oldenburger F, De Camargo B, Ramirez G, Bergeron C, Pritchard-Jones K, Graf N, Van den Heuvel-Eibrink MM
Prognostic significance of age in 5631 patients with Wilms tumor prospectively registered in International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001.
PLOS ONE 14(8): e0221373 2019; doi: 10.1371/journal.pone.0221373 -> Abstract
Tim H. H. Coorens, Taryn D. Treger, Reem Al-Saadi, Luiza Moore, Maxine G. B. Tran, Thomas J. Mitchell, Suzanne Tugnait, Christine Thevanesan, Matthew D. Young, Thomas R. W. Oliver, Minou Oostveen, Grace Collord, Patrick S. Tarpey, Alex Cagan, Yvette Hooks, Mark Brougham, Ben C. Reynolds, Giuseppe Barone, John Anderson, Mette Jorgensen, G. A. Amos Burke, Johannes Visser, James C. Nicholson, Naima Smeulders, Imran Mushtaq, Grant D. Stewart, Peter J. Campbell, David C. Wedge, Iñigo Martincorena, Dyanne Rampling, Liz Hook, Anne Y. Warren, Nicholas Coleman, Tanzina Chowdhury, Neil Sebire, Jarno Drost, Kourosh Saeb-Parsy, Michael R. Stratton, Karin Straathof, Kathy Pritchard-Jones, Sam Behjati
Embryonal precursors of Wilms tumor.
Science 06 Dec 2019: Vol. 366, Issue 6470, pp. 1247-1251 doi: 10.1126/science.aax1323 -> Abstract; Supplementary Materials
Treger TD, Chowdhury T, Pritchard-Jones K, Behjati S
The genetic changes of Wilms tumour.
Nat Rev Nephrol. 2019 Jan 31. doi: 10.1038/s41581-019-0112-0 -> Abstract
D´Hooghe E, Mifsud W, Vujanić G
“Teratoid” Wilms Tumor. The Extreme End of Heterologous Element Differentiation, Not a Separate Entity
Am J Surg Pathol 43:1583–1590, 2019; doi: 10.1097/PAS.0000000000001335 -> Abstract
Morris L, Squire R, Sznajder B, van Tinteren H, Godzinski J, Powis M
Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial.
Pediatr Blood Cancer, 2019; 66:e27930; doi: 10.1002/pbc.27930 ->Abstract
Spreafico F, Dalissier A, Pötschger U, Locatelli F, Michon J, Peters C, Bader P, Bisogno G, Yeomanason D, Willasch A, van den Heuvel Eibrink M, Graf N, Dallorso S
High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: A study of the European society for Blood and Marrow Transplantation.
Nature Bone Marrow Transplantation 2019; doi: 10.1038/s41409-019-0661-7 ->Abstract
Guerra JVDS, Pereira BMS, Cruz JGVD, Scherer NM, Furtado C, Montalvão de Azevedo R, Oliveira PSL, Faria P, Boroni M, de Camargo B, Maschietto M
Genes Controlled by DNA Methylation Are Involved in Wilms Tumor Progression.
Cells 17:8 pii: E921, 2019. doi: 10.3390/cells8080921 ->Abstract
Brillantino C, Rossi E, Minelli R, Bignardi E, Coppola M, Zeccolini R, Zeccolini M
Current Role of Imaging in the Management of Children with Wilms Tumor According to the New UMBRELLA Protocol.
Translational Medicine 8:1-16, 2019. doi: 10.24105/2161-1025.9.206 ->Abstract
Morris L, Squire R, Szajder B, van Tinteren H, Godzinski J, Powis M
Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOPWT2001 trial.
Pediatr Blood Cancer. 2019 Jul 24:e27930. doi: 10.1002/pbc.27930 ->Abstract
Vokuhl C
Seltene kindliche Nierentumoren.
Pathologe. 2019 Jul 23. doi: 10.1007/s00292-019-0638-8 ->Abstract
Kaba D, McFarlane N, Dong F, Graf N, Xujiong Ye
Nephroblastoma analysis in MRI images.
Image Anal Stereol 38:173-183, 2019 doi:10.5566/ias.2000 ->Abstract
Müller S, Farag I, Weickert J, Braun Y, Lollert A, Dobberstein J, Hötker A, Graf N
Benchmarking Wilms’ tumor in multisequence MRI data: why does current clinical practice fail? Which popular segmentation algorithms perform well?
J Medical Imaging 6(3), 034001, 2019; doi: 10.1117/1.JMI.6.3.034001 ->Abstract
Sabine Irtan, Harm Van Tinteren, Norbert Graf, Marry van den Heuvel-Eibrink, Hugo Heij, Christophe Bergeron, Beatriz de Camargo, Tomas Acha, Filippo Spreafico, Gordan Vujanic, Mark Powis, Bruce Okoye, Jim Wilde, Jan Godzinski, Kathy Pritchard-Jones
Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms Tumour in the SIOP WT 2001 trial.
Eur J Cancer 116:13-20, 2019 doi: 10.1016/j.ejca.2019.04.027 ->Abstract PubMed
Bianca A Hoeben, Christian Carrie, Beate Timmermann, Henry C Mandeville, Lorenza Gandola, Karin Dieckmann, Monica Ramos Albiac, Henriette Magelssen, Yasmin Lassen-Ramshad, Barbora Ondrová, Thankamma Ajithkumar, Claire Alapetite, Brian V Balgobind, Stephanie Bolle, Alison L Cameron, Raquel Davila Fajardo, Stefan Dietzsch, Delphine Dumont Lecomte, Marry M van den Heuvel-Eibrink, Rolf D Kortmann, Anne Laprie, Patrick Melchior, Laetitia Padovani, Barbara Rombi, Giovanni Scarzello, Rudolf Schwarz, Klaus Seiersen, Enrica Seravalli, Nicola Thorp, Gillian A Whitfield, Tom Boterberg, Geert O Janssens
Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
Lancet Oncology. 2019 Mar;20(3): e155–66 doi: 10.1016/S1470-2045(19)30034-8. ->Abstract PubMed
Thomas J. Jackson, Gordan M. Vujanić, Kathy Pritchard-Jones
Comment on: "Indications and results of diagnostic biopsy in pediatric renal tumors: A retrospective analysis of 317 patients with critical review of SIOP guidelines"
Pediatr Blood Cancer. 2019 Apr 02;:e27746 doi: 10.1002/pbc.27746. [Epub ahead of print] ->Abstract PubMed
Kathy Pritchard-Jones, Perotti D
WARNING: G-401 and SK-NEP-1 cell lines are not Wilms tumor cell lines.
Pediatr Blood Cancer. 2019; e27741 doi: 10.1002/pbc.27741. [Epub ahead of print] ->Abstract PubMed
Shazia Mahamdallie, Shawn Yost, Emma Poyastro-Pearson, Esty Holt, Anna Zachariou, Sheila Seal, Anna Elliott, Matthew Clarke, Margaret Warren-Perry, Sandra Hanks, John Anderson, Simon Bomken, Trevor Cole, Roula Farah, Rhoikos Furtwaengler, Adam Glaser, Richard Grundy, James Hayden, Steve Lowis, Frédéric Millot, James Nicholson, Milind Ronghe, Jane Skeen, Denise Williams, Daniel Yeomanson, Elise Ruark, Nazneen Rahman
Identification of new Wilms tumour predisposition genes: an exome sequencing study
Lancet Child Adolesc Health, 2019 doi: 10.1016/S2352-4642(19)30018-5. [Epub ahead of print] ->Abstract PubMed
Jackson TJ, Williams RD, Brok J, Chowdhury T, Ronghe M, Powis M, Pritchard-jones K, Vujanic GM on behalf of the Children's Cancer and Leukaemia Group (CCLG) Renal Tumours Group
The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial
Pediatr Blodd Cancer, 2019, doi: 10.1002/pbc.27627. [Epub ahead of print] ->Abstract PubMed
de la Monneraye Y, Michon J, Pacquement H, Aerts I, Orbach D, Doz F, Bourdeaut F, Sarnacki S, Philippe-Chomette P, Audry G, Coulomb A, Fréneaux P, Klijanienko J, Berrebi D, Zucker JM, Schleiermacher G, Brisse HJ
Indications and results of diagnostic biopsy in pediatric renal tumors: A retrospective analysis of 317 patients with critical review of SIOP guidelines
Pediatr Blodd Cancer, 2019, doi: 10.1002/pbc.27641. [Epub ahead of print] ->Abstract PubMed
Illja J. Diets, Juliane Hoyer, Arif B Ekici, Bernt Popp, Nicoline Hoogerbrugge, Simon van Reijmersdal, Rajith Bhaskaran, Michel Hadjihannas, Georgia Vasileiou, Christian T. Thiel, Didem Seven, Steffen Uebe, Denisa Ilencikova, Esmé Waanders, Annelies MC Mavinkurve, Nel Roeleveld, Ronald de Krijger, Jenny Wegert, Norbert Graf, Christian Vokuhl, Abbas Agaimy, Manfred Gessler, André Reis, Roland P. Kuiper, Marjolijn C. Jongmans, Markus Metzler
TRIM28 haploinsufficiency predisposes to Wilms tumor
Int J Cancer, 2019, doi: 10.1002/ijc.32167. [Epub ahead of print] ->Abstract PubMed
Vujanic GM, Lena MS, Sebire NJ
Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties
Virchows Archiv 474:227-234, 2019, doi: 10.1002/pbc.27549 ->Abstract PubMed
Vujanic GM, D'Hooghe E, Popov SD, Sebire NJ, Kelsey A
The effect of preoperative chemotherapy on histological subtyping and staging ofWilms tumors: The United Kingdom Children's Cancer Study Group (UKCCSG)Wilms tumor trial 3 (UKW3) experience
Pediatr Blood Cancer 66:e27549, 2019, doi: 10.1002/pbc.27549 ->Abstract PubMed
Kehl T, Schneider L, Kattler K, Stöckel D, Wegert J, Gerstner N, Ludwig N, Distler U, Tenzer S, Gessler M, Walter J, Keller A, Graf N, Meese E, Lenhof HP
The role of TCF3 as potential master regulator in blastemal Wilms tumors
Int J Cancer 144:1432-1443, 2019. doi: 10.1002/ijc.31834->Abstract PubMed
Irtan S, Messahel B, Moroz V, Taylor RF, Grundy R, Kelsey A, Vujanic G, Pritchard-Jones K on behalf of the Renal Tumours Committee of the Children's Cancer and Leukaemia Group (CCLG)
Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial
Radiotherapy and Oncology 131:1-7, 2019, doi: 10.1016/j.radonc.2018.10.026 -> Abstract Pubmed
Oostveen RM, Pritchard-Jones K
Pharmacotherapeutic Management of Wilms Tumor: An Update
Pediatric Drugs, 2019, doi: 10.1007/s40272-018-0323-z -> Abstract Pubmed
